The Weekly Dose: 5/13/25

This week, three major forces collided: the SURMOUNT-5 results, CVS Caremark’s shocking coverage decision, and a new Executive Order. Here’s what it means for you, and what you can do next.

Let’s talk about what just happened.

CVS Caremark decided to pull Zepbound from its preferred formulary.
That means if your insurance is through CVS, you could lose access on July 1.

No conversation. No explanation. Just gone.

They replaced it with Wegovy.
Even though we now have the strongest data ever published showing Zepbound blows Wegovy out of the wate…